Lumax Auto Technologies (LUMAXTECH) Q4 19/20 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 19/20 earnings summary
15 Oct, 2026Executive summary
Consolidated revenue from operations was ₹1,140.91cr, down 3.88% YoY; EBITDA margin eased to 9.5% from 10.4%, amid a prolonged auto-market downturn and COVID-19 disruption.
Operations adapted with workforce safety measures, a broadened R&D agenda, BS VI-ready products and new technology partnerships.
Financial highlights
Consolidated EBITDA was ₹108.75cr vs ₹123.86cr; PAT after minority interest was ₹49.79cr vs ₹53.23cr; EPS from continuing operations was ₹7.30 vs ₹7.81.
Standalone continuing-operations revenue was ₹942.36cr, down 2% YoY; PBT was ₹61.25cr vs ₹71.92cr, while PAT rose to ₹51.27cr from ₹46.91cr.
PCB business asset sales generated ₹9.49cr profit before tax and ₹8.25cr profit after tax, reported as discontinued operations.
OCI included a ₹51.14cr loss on FVTOCI equity securities, contributing to consolidated total comprehensive income of ₹8.39cr vs ₹51.59cr.
Outlook and guidance
Industry estimates projected OEM component volumes to decline 7%–15% across vehicle classes and exports to fall 15% in value; replacement demand was expected to grow 3%.
Track-and-trace products had entered OEM trials, with revenue expected from FY2020-21; the oxygen-sensor plant was under commissioning, with commercial production expected in Q3 FY2020-21.
The OK Play auto-component business acquisition was put on hold pending further review because of the pandemic and extended lockdowns.
Latest events from Lumax Auto Technologies
- Revenue softened, but EBITDA and margins improved through pandemic-driven disruption.LUMAXTECH
Q4 20/21 - FY24 revenue surged 53%, with record EBITDA and profit following IAC integration.LUMAXTECH
Q4 23/24 - FY23 growth accelerated as IAC expanded passenger-vehicle exposure and debt rose.LUMAXTECH
Q4 22/23 - Record FY22 growth met supply-chain headwinds as technology and aftermarket expansion drove outlook.LUMAXTECH
Q4 21/22 - Revenue and profit grew strongly as BS-VI products and new JVs built momentum.LUMAXTECH
Q4 18/19 - Revenue grew 15%, PAT 41%, and EBITDA margin expanded 170 bps.LUMAXTECH
Q4 17/18 - Subsidiary and JV growth offset standalone weakness, lifting FY17 consolidated revenue 11.84%.LUMAXTECH
Q4 16/17 - Revenue grew 8.12%, with aftermarket expansion balancing industry and cost risks.LUMAXTECH
Q4 15/16 - Flat consolidated sales, lower profits, and expansion through new plants and JVs.LUMAXTECH
Q4 13/14